Chroman 1

Chroman 1 is a highly potent and selective ROCK inhibitor. Chroman 1 is more potent against ROCK2 (IC50=1 pM) than ROCK1 (IC50=52 pM) . Chroman 1 also has inhibitory activity against MRCK, with an IC50 of 150 nM[1][2].

Product Specifications

CAS Number

[1273579-40-0]

UNSPSC

12352005

Hazard Statement

H302, H315, H319

Target

ROCK

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad

Applications

COVID-19-anti-virus

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/chroman-1.html

Purity

99.42

Solubility

DMSO : ≥ 50 mg/mL

Smiles

O=C([C@@H]1COC2=CC=C(OC)C=C2C1)NC3=CC=C(C4=CNN=C4)C=C3OCCN(C)C

Molecular Formula

C24H28N4O4

Molecular Weight

436.50

Precautions

H302, H315, H319

References & Citations

[1]Yen Ting Chen, et al. Asymmetric synthesis of potent chroman-based Rho kinase (ROCK-II) inhibitors. Med.Chem.Commun., 2011, 2, 73-75.|[2]Yu Chen, et al. A Versatile Polypharmacology Platform Promotes Cytoprotection and Viability of Human Pluripotent and Differentiated Cells. bioRxiv 815761.